About
Bio
Addresses the immediate needs of biotechnology professionals and investors who desire comprehensive coverage of the latest news. The magazine also covers the business and science of biopharmaceuticals - company financials, mergers and acquisitions, collaborations and licensing deals, VC funding, technology transfers and executive moves.
It also covers financings, deals, FDA approvals, trial initiations, preclinical and clinical data, regulatory news, commercial biotech earnings, conferences and new companies. The magazine does not cover diagnostics or medical devices unless they are specifically related to the development of a biopharmaceutical.
The publication has news meetings daily at 10 a.m. EST and the daily copy deadline is 4:30 p.m. EST.
BioWorld editors also attend industry events such as BIO International and the JP Morgan Healthcare Conference as well as the major medical meetings.
For regulatory news, pitch the Washington Editor. For publications or presentations of early stage research, pitch the Science Editor. For trends and analysis appropriate for BioWorld Insight, pitch the Insight Editor. They are otherwise beat-agnostic. As mentioned, news can always be sent to newsdesk@bioworld.com – this account is monitored throughout business hours. The BioWorld Today editorial news meeting happens daily at 10 a.m. EST. That’s when they pick the stories for the day, so if you have news that’s complex and needs explanation (i.e. a deal with no terms, but an interesting structure), please reach out to them before then. Their daily copy deadline (the time when stories must be completed by our writers) is 4:30 p.m. EST.
The Publication ask that all press releases be sent to, or at least copied to the main email.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United States of America
Frequency
upgrade
Circulation
upgrade
Sectors
Biotechnology
Bio
Addresses the immediate needs of biotechnology professionals and investors who desire comprehensive coverage of the latest news. The magazine also covers the business and science of biopharmaceuticals - company financials, mergers and acquisitions, collaborations and licensing deals, VC funding, technology transfers and executive moves. It also covers financings, deals, FDA approvals, trial initiations, preclinical and clinical data, regulatory news, commercial biotech earnings, conferences and new companies. The magazine does not cover diagnostics or medical devices unless they are specifically related to the development of a biopharmaceutical. The publication has news meetings daily at 10 a.m. EST and the daily copy deadline is 4:30 p.m. EST. BioWorld editors also attend industry events such as BIO International and the JP Morgan Healthcare Conference as well as the major medical meetings. For regulatory news, pitch the Washington Editor. For publications or presentations of early stage research, pitch the Science Editor. For trends and analysis appropriate for BioWorld Insight, pitch the Insight Editor. They are otherwise beat-agnostic. As mentioned, news can always be sent to newsdesk@bioworld.com – this account is monitored throughout business hours. The BioWorld Today editorial news meeting happens daily at 10 a.m. EST. That’s when they pick the stories for the day, so if you have news that’s complex and needs explanation (i.e. a deal with no terms, but an interesting structure), please reach out to them before then. Their daily copy deadline (the time when stories must be completed by our writers) is 4:30 p.m. EST. The Publication ask that all press releases be sent to, or at least copied to the main email.
Website
Social media
Location
Frequency
Circulation
Sectors
Biotechnology
Most recent articles by BioWorld Today
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to BioWorld Today
-
SScientific American
Established in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.
ViewPPopular MechanicsPublished by Hearst and established in 1902, Popular Mechanics is designed to satisfy the reader's passion to know how and why things work. The publication covers how today's technologies affect the things readers are most interested in: their homes, consumer electronics, cars, science, computers, sports, and current events, and explains the way the world works in the 21st century. Editorial engages readers with breakthroughs on the latest advances in science and technology, and educates with informative how-to stories on digital technology, automotive, and the home. It also motivates minds to act with product reviews and comparisons on all of the latest equipment and products. Articles are broken into five departments: - Technology: covering the Internet, personal computers, computer games, and other consumer electronics - Automotive: featuring articles about new car models, motor sports, and automotive repair and maintenance - Science: covering general interest health, technology, and physical science topics - Home: offering home maintenance and renovation information - Outdoors: covering sports and outdoor recreation Other editorial sections include: - Technology Watch: a front-of-book section offering short news items on technology, aviation, environment, energy, computers, robotics, space, transportation, health, and military - Spy Report: comprehensive sneak peeks of cars and trucks coming out of the U.S., Europe, and Asia - Great Stuff: listing new home, automotive, recreation, consumer electronics, and fitness products - Time Machine: revisiting article topics from 90, 60, and 30 years ago
ViewMMIT Technology ReviewEstablished in 1899 and written for venture capitalists and hi-tech executives as an informational source on innovative and improved technologies and their applications. Focuses on promoting the understanding of emerging technologies and their impact. Strives to promote the understanding of emerging technology and its impact on the world. Aims to promote the understanding of emerging technologies and to analyze their commercial, social and political impacts. Assists technology and business leaders including CXOs, entrepreneurs, researchers, venture capitalists and financiers as they drive the global economy.
ViewEEndpoints NewsEndpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).
ViewNature Reviews Drug DiscoveryImpact Factor:22.66 (Source: Scimago Journal & Country Rank)Circulation: The figure is not currently disclosed.Aims of the journal:Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition it seeks to provide the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Content: The journal covers the following subjects: Target discovery Rational drug design Combinatorial and parallel synthesis Medicinal chemistry Key compound classes Natural products High-throughput screening Novel therapeutic approaches to disease states Microarrays Bioinformatics and chemoinformatics Absorption, distribution, metabolism and elimination (ADME) Pharmacokinetics and pharmacodynamics Pharmacology Toxicology Pharmacogenomics and toxicogenomics Drug delivery Biopharmaceuticals Biotechnology Vaccines Clinical trial evaluation Regulatory issues PharmacoeconomicsEditorial contacts: See the list of editors here.The editorial office can be reached at naturereviews@nature.com.Manuscript submission:To be published in nature Reviews Drug Discovery a manuscript should meet the following criteria: Timely, accurate and balanced Important to scientists in the specific field Interesting and accessible to researchers in other areas of Drug DiscoverySubmit online at http://mts-nrdd.nature.com/cgi-bin/main.plex
ViewUse CisionOne to find more relevant outletsExplore journalists that write for BioWorld Today
-
M
-
N
Contact us to find more relevant journalistsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.